ArticlePharmacoEconomics - open2021

Non-Price-Related Determinants of Value and Access for Novel Non-small Cell Lung Cancer Treatments: A Cross-Country Review of HTA Decision Making.

Jason Gordon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.